'''Aptazapine''' (developmental code name '''CGS-7525A''') is a [[tetracyclic antidepressant]] (TeCA) which was assayed in [[clinical trial]]s for the treatment of [[major depression|depression]] in the 1980s but was never marketed.<ref name="pmid6131367">{{cite journal |vauthors=Liebman JM, Lovell RA, Braunwalder A | title = CGS 7525A, a new, centrally active alpha 2 adrenoceptor antagonist | journal = Life Sciences | volume = 32 | issue = 4 | pages = 355–63 |date=January 1983 | pmid = 6131367 | doi = 10.1016/0024-3205(83)90081-4| url = |display-authors=etal}}</ref><ref name="isbn0-12-040520-2">{{cite book | author = Author Unknown | title = Annual Reports in Medicinal Chemistry (Volume 20) | publisher = Academic Press | location = Boston | year = 1985 | pages = 352 | isbn = 0-12-040520-2 | oclc = | doi = | url = https://books.google.com/books?id=j-3Cd_SWIksC&lpg=PA33&dq=aptazapine&pg=PA33#v=onepage&q=aptazapine&f=false}}</ref><ref name="isbn0-412-46630-9">{{cite book | author = David J. Triggle | title = Dictionary of pharmacological agents | publisher = Chapman & Hall | location = London | year = 1997 | pages = | isbn = 0-412-46630-9 | oclc = | doi = | url = https://books.google.com/books?id=DeX7jgInYFMC&lpg=PA167&dq=aptazapine&pg=PA167#v=onepage&q=aptazapine&f=false}}</ref> It is a [[potency (pharmacology)|potent]] [[alpha-2 adrenergic receptor|α<sub>2</sub>-adrenergic receptor]] [[receptor antagonist|antagonist]] with ~10x the strength of the related compound [[mianserin]] and has also been shown to act as a [[5-HT2 receptor|5-HT<sub>2</sub> receptor]] [[receptor antagonist|antagonist]] and [[H1 receptor|H<sub>1</sub> receptor]] [[inverse agonist]], while having no significant effects on the [[reuptake]] of [[serotonin]] or [[norepinephrine]].<ref name="pmid6131367"/><ref name="pmid2896489">{{cite journal |vauthors=Gower AJ, Broekkamp CL, Rijk HW, Van Delft AM | title = Pharmacological evaluation of in vivo tests for alpha 2-adrenoceptor blockade in the central nervous system and the effects of the enantiomers of mianserin and its aza-analog ORG 3770 | journal = Archives Internationales de Pharmacodynamie et de Thérapie | volume = 291 | issue = | pages = 185–201 | year = 1988 | pmid = 2896489 | doi = | url = }}</ref> Based on its pharmacological profile, aptazapine may be classified as a [[noradrenergic and specific serotonergic antidepressant]] (NaSSA).
